Commercial or Open Source Closed Loop Impact on Pregnancy Study

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Oct 21, 2024

Keywords

ClinConnect Summary

This clinical trial, called the Commercial or Open Source Closed Loop Impact on Pregnancy Study, is looking at how automated insulin delivery (AID) systems affect pregnant people who have type 1 diabetes (T1D). The researchers want to learn more about the outcomes for both mothers and their babies, how well blood sugar levels are managed, and the emotional and behavioral experiences of those using these systems during pregnancy. They will compare two types of AID systems: commercial systems that are sold by companies and open-source systems that are developed by users.

To participate, you need to be pregnant, have been diagnosed with type 1 diabetes before becoming pregnant, and actively use an AID system. Unfortunately, those with other types of diabetes, such as gestational or type 2 diabetes, are not eligible for this study. If you join, you will share information from your AID system with the research team, complete online surveys about your emotional well-being, and allow the team to access your medical records. This study is currently recruiting participants, and it aims to provide valuable insights into how these systems can support pregnant individuals with diabetes.

Gender

FEMALE

Eligibility criteria

• Inclusion criteria:
• • Pregnant
• • Diagnosis of type 1 diabetes (T1D) prior to pregnancy
• • Active use of automated insulin delivery (AID) system
• Exclusion criteria:
• • Diagnosis of other forms of diabetes (gestational diabetes, type 2 diabetes, monogenic diabetes)